Ionis Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-12.92-23.33-66.3841.08
Price/Sales ratio
7.835.624.623.57
Earnings per Share (EPS)
$-3.28$-1.82$-0.63$1.03

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-186.39-83.68-66.75-1.04K26.1328.76-16.20-147.97-19.84-19.77-19.6028.76
Price/Sales ratio
33.9226.0416.6612.2811.927.5310.825.299.129.199.009.00
Price/Book Value ratio
28.1836.7958.0318.856.825.749.365.559.3518.739.226.82
Price/Cash Flow ratio
1.15K349.72-51.5335.8111.8624.46219.92139.33-19.52-23.55-19.2624.46
Price/Free Cash Flow ratio
-1.50K787.87-46.7345.7612.2227.33-1.53K332.70-18.19-21.59-17.9527.33
Price/Earnings Growth ratio
4.65-0.6724.6911.19-0.0019.840.061.57-0.02-0.560.02-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-12.88%-13.60%0.66%26.20%99.69%99.64%98.35%98.64%97.61%98.84%97.59%99.64%
Operating Profit Margin
-22.28%-26.70%-13.36%4.83%-10.23%32.59%-23.59%-3.70%-70.01%-44.90%-69.81%32.59%
Pretax Profit Margin
-25.39%-30.98%-24.12%-4.58%-12.69%30.89%-23.31%-3.70%-43.95%-42.40%-43.92%30.89%
Net Profit Margin
-18.20%-31.11%-24.97%-1.17%45.64%26.17%-66.80%-3.58%-45.99%-46.50%-45.92%26.17%
Effective Tax Rate
28.32%-0.42%-3.50%25.69%382.29%12.68%-186.47%3.33%-4.65%-9.67%-4.54%12.68%
Return on Assets
-4.07%-9.23%-9.48%-0.45%10.26%9.09%-20.37%-1.11%-10.65%-12.25%-10.64%9.09%
Return On Equity
-15.12%-43.96%-86.93%-1.80%26.11%19.98%-57.76%-3.75%-47.12%-94.72%-43.12%19.98%
Return on Capital Employed
-5.67%-9.38%-5.94%2.23%-2.57%12.36%-8.19%-1.26%-18.49%-13.91%-18.45%12.36%
Liquidity Ratios
Current Ratio
7.255.625.965.197.879.963.65N/AN/AN/A7.069.96
Quick Ratio
7.195.575.905.157.849.907.269.626.995.836.459.90
Cash ratio
6.315.234.974.557.439.156.528.776.360.890.889.15
Days of Sales Outstanding
6.6514.61113.7745.267.7620.4838.1527.8915.8745.3115.867.76
Days of Inventory outstanding
9.497.817.939.721.72K1.65K668.10823.10574.431.13K569.711.65K
Operating Cycle
16.1422.42121.7154.981.72K1.67K706.25850.99590.311.18K573.621.67K
Days of Payables Outstanding
27.1532.1122.3824.245.74K1.46K523.13394.99467.221.04K463.381.46K
Cash Conversion Cycle
-11.00-9.6899.3230.74-4.01K213.29183.12456.00123.08141.14-307.04-4.01K
Debt Ratios
Debt Ratio
0.400.410.560.410.210.220.390.440.460.600.770.21
Debt Equity Ratio
1.491.995.191.650.550.491.101.502.074.643.420.55
Long-term Debt to Capitalization
0.590.660.830.620.350.330.420.600.670.810.700.35
Total Debt to Capitalization
0.590.660.830.620.350.330.520.600.670.820.700.35
Interest Coverage Ratio
-2.14-2.06-1.190.54-1.377.50-3.82N/AN/AN/A-50.497.50
Cash Flow to Debt Ratio
0.010.05-0.210.311.020.470.030.02-0.23-0.17-0.200.47
Company Equity Multiplier
3.704.769.163.992.542.192.833.384.427.734.422.54
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.020.07-0.320.341.000.300.040.03-0.46-0.39-0.460.30
Free Cash Flow / Operating Cash Flow Ratio
-0.760.441.100.780.970.89-0.140.411.071.091.070.97
Cash Flow Coverage Ratio
0.010.05-0.210.311.020.470.030.02-0.23-0.17-0.200.47
Short Term Coverage Ratio
2.182.33-94.60107.4343.84170.640.118.73-36.41-5.78-36.41170.64
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A